BioCentury
ARTICLE | Clinical News

Aurix System: Phase IV started

April 6, 2015 7:00 AM UTC

Nuo began the open-label, U.S. Phase IV Au Study to compare Aurix System plus standard of care (SOC) vs. SOC alone in about 760 patients with diabetic foot ulcers, 640 patients with venous leg ulcers and 800 patients with pressure ulcers. The company is conducting the trial under CMS’s coverage with evidence development (CED) program. ...